Chemoinformaics analysis of APIGENIN-7-O-BETA-D-GALACTOMANNOSIDE
Molecular Weight | 594.522 | nRot | 7 |
Heavy Atom Molecular Weight | 564.282 | nRig | 30 |
Exact Molecular Weight | 594.158 | nRing | 5 |
Solubility: LogS | -3.345 | nHRing | 3 |
Solubility: LogP | -0.629 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 72 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 42 | No. of Aromatic Carbocycles | 2 |
nHetero | 15 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 15 | No. of Arom Bond | 17 |
nHA | 15 | APOL | 77.1238 |
nHD | 9 | BPOL | 39.6442 |
QED | 0.142 |
Synth | 4.622 |
Natural Product Likeliness | 1.684 |
NR-PPAR-gamma | 0.888 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.966 |
HIA | 0.973 |
CACO-2 | -6.282 |
MDCK | 0.0000947 |
BBB | 0.33 |
PPB | 0.761096 |
VDSS | 0.528 |
FU | 0.233027 |
CYP1A2-inh | 0.012 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.01 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.001 |
CYP2c9-sub | 0.37 |
CYP2d6-inh | 0.005 |
CYP2d6-sub | 0.165 |
CYP3a4-inh | 0.009 |
CYP3a4-sub | 0.005 |
CL | 1.242 |
T12 | 0.297 |
hERG | 0.067 |
Ames | 0.573 |
ROA | 0.029 |
SkinSen | 0.028 |
Carcinogencity | 0.66 |
EI | 0.009 |
Respiratory | 0.017 |
NR-Aromatase | 0.934 |
Antiviral | Yes |
Prediction | 0.838793 |